Bailard, Inc. Harvard Bioscience Inc Transaction History

Bailard, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$4.02 - $5.39 $26,077 - $34,964	-6,487 Reduced 32.9%	13,233 $56,000
Q4 2023 Feb 02, 2024	BUY	$4.0 - $5.49 $78,880 - $108,262	19,720 New	19,720 $105,000
Q2 2022 Jul 27, 2022	BUY	$3.28 - $6.42 $88,081 - $172,402	26,854 New	26,854 $97,000
Q1 2022 Apr 25, 2022	SELL	$5.16 - $7.14 $75,852 - $104,958	-14,700 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$6.37 - $8.18 $93,639 - $120,246	14,700 New	14,700 $104,000
Q4 2020 Feb 03, 2021	SELL	$3.0 - $4.5 $55,500 - $83,250	-18,500 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$2.75 - $4.2 $50,875 - $77,700	18,500 New	18,500 $56,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.